An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative Colitis

Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)

NCT00307827 ·Status: TERMINATED ·Phase: PHASE2

Research Study in Patients With Severe Ulcerative Colitis

NCT00032305 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Special Drug-Use Surveillance Study on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis]

NCT03824561 ·Status: COMPLETED

Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis

NCT03029143 ·Status: COMPLETED ·Phase: PHASE4

EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis

NCT03679546 ·Status: COMPLETED ·Phase: PHASE4

The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness

NCT02423512 ·Status: COMPLETED

A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors

NCT02163759 ·Status: COMPLETED ·Phase: PHASE3

Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease

NCT02425111 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors

NCT02165215 ·Status: COMPLETED ·Phase: PHASE3

Real World Data on Vedolizumab Concentration and Outcomes in Inflammatory Bowel Disease (IBD) Patients Switching From Intravenous (IV) to Subcutaneous (SC) Vedolizumab in University Hospital Center Osijek

NCT05504915 ·Status: COMPLETED

Ulcerative Colitis Study: Study of Visilizumab in Patients With Severe Ulcerative Colitis

NCT00267306 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Fistulizing Crohn's Disease

NCT00269841 ·Status: COMPLETED ·Phase: PHASE3

An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis

NCT02497469 ·Status: COMPLETED ·Phase: PHASE3

A Study To Investigate The Safety And Efficacy Properties Of PF-00547659 In Patients With Active Ulcerative Colitis

NCT00928681 ·Status: COMPLETED ·Phase: PHASE1

Feasibility Pilot Sequential Multiple Assignment Randomized Trial (SMART) for Acute Severe Ulcerative Colitis

NCT05867329 ·Status: RECRUITING ·Phase: PHASE4

A Study to Evaluate the Safety of PRV-300 in Adult Subjects With Moderately to Severely Active Ulcerative Colitis

NCT03849599 ·Status: COMPLETED ·Phase: PHASE1

Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis

NCT05907330 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Clinical Outcome After Escalation and De-escalation of Adalimumab in Real Life in Ulcerative Colitis

NCT03142113 ·Status: COMPLETED

Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)

NCT05817942 ·Status: ACTIVE_NOT_RECRUITING

Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis

NCT02065622 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis

NCT04877990 ·Status: COMPLETED ·Phase: PHASE2

A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors

NCT02171429 ·Status: COMPLETED ·Phase: PHASE3

Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease

NCT03801928 ·Status: COMPLETED

A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors

NCT02100696 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis

NCT06095596 ·Status: RECRUITING ·Phase: NA